Positive list system may not save NHI finance.

The pharmaceutical industry suggested a way of better NHI financial saving than the positive list system, which included more patient's own payment for minor disease treatments, reclassification of the prescription and non-prescription drugs and more tough NHI drug price approval system.

Accordingly, the industry said that the positive list system could not be an ideal alternative way of sav...